Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodelling

International Orthopaedics

Volumn 31, Issue 6, 2007, Pages 753-757

  Sendak, Rebecca A ^a   Sampath, T Kuber ^a   McPherson, John M ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; FOLLITROPIN; FOLLITROPIN RECEPTOR; PARATHYROID HORMONE[1-34]; RECOMBINANT THYROTROPIN; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR;

ADRENERGIC SYSTEM; ARCHITECTURE; BONE DENSITY; BONE MASS; BONE REMODELING; BONE STRENGTH; CORRELATION ANALYSIS; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; GENE MUTATION; HOMEOSTASIS; HORMONE ACTION; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; REVIEW; THYROIDECTOMY;

ANIMALS; BONE DENSITY; BONE REMODELING; DISEASE MODELS, ANIMAL; FOLLICLE STIMULATING HORMONE; MICE; OSTEOPOROSIS; RATS; THYROTROPIN;

EID: 36348981562     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-007-0417-7     Document Type: Review

References (19)

1. Abe E, Marians RC, Yu W, Wu X-B, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M (2003) TSH is a negative regulator of skeletal remodeling. Cell 115:151-162
2. Bassett JHD, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PGT, Weiss RE, Roux J-P, Malaval L, Clement-Lacroix P, Samarut J, Chassande O, Williams GR (2007) Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 21:1095-1107
3. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P (1998) Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Cell Biol 95:13612-13617
4. Greenspan SL, Greenspan FS (1999) The effect of thyroid hormone on skeletal integrity. Ann Intern Med 130:750-758
5. Grossman M, Weintraub BD, Szkudlinski MW (1997) Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr Rev 18:476-501
6. Hase H, Ando T, Eldeiry L, Brebene A, Peng Y, Lin L, Amano H, Davies TF, Sun L, Zaidi M, Abe E (2006) TNFα mediates the skeletal effects of thyroid-stimulating hormone. Proc Natl Acad Sci USA 103:12849-12854
7. Ibqal J, Sun L, Kumar TR, Blair HC, Zaidi M (2006) Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 103:14925-14930
8. Kim DJ, Khang YH, Koh J-M, Shong YK, Kim GS (2006) Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clin Endocrinol 64:86-90
9. Martini G, Pacini F, Campagna, MS, Fanci B, Azvanzati A, Lucani B, Salvadori S, Gennari L, Valenti R, DePaola V, Pilli T, Nuti R (2005) The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. In: Presentation SU378 of the American Society for Bone and Mineral Research (ASBMR) 27th Annual Meeting, Nashville, Tennessee, September 2005
10. Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pillo P, Biondi B, Iorio S, Giustina A, Amato G, Carelly C (2005) Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 20:480-486
11. Morris MS (2007) The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone 40:1128-1134
12. Onigata K, Kowasi T, Nishiyama S, Micuno H, Morikawa A (2005) Bone mineral density in human cases with TSH receptor gene mutations. In: Proceedings of the New York Academy of Sciences 1st Conference on Skeletal Development and Remodeling in Health, Disease, and Aging, New York, May 2005, vol 1, p 11
13. Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099-1106
14. Ramirez L, Braverman LE, White B, Emerson CH (1997) Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 82:2836-2839
15. Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S (2007) Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. J Bone Miner Res 22:849-859
16. Sun L, Davies TF, Blair HC, Abe E, Zaidi M (2006) TSH and bone loss. Ann NY Acad Sci 1068:309-318
17. Sun L, Zhang Z, Iqbal J, Zaidi S, Papachristou DJ, Zhou H, Sharrow AC, Peng Y, Yaroslavskiy BB, Zhu L-L, Zallone A, Sairam MR, Kumkar TR, Landa LC, Schaffler MB, Moonga BS, Blaire HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125:247-260
18. Szkudlinski MW, Grossmann M, Leitolf H, Weintraub BD (2000) Human thyroid-stimulating hormone: structure-function analysis. Methods 21:67-81
19. Zaidi M (2005) Neural surveillance of skeletal homeostasis. Cell Metab 1:219-221